| Malignant Nervous System Neoplasm altered in cohorts of …ALTERED_INderived112 of 112show fewer |
|---|
| ← altered in cohorts of | PTEN 461 / 601 cases (77 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATRNL1 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYOF 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC23IP 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BAG3 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACUL1 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EGFR 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF3A 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INPP5F 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCMBP 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRLHR 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SORBS1 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTA2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTBP2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP26C1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND10 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GFRA1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRK5 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSPA12A 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPK 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NANOS1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDZD8 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLPP4 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIPRP1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIPRP3 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRDX3 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB11FIP2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RGS10 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SFXN4 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC18A2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBC1D12 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TIAL1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABRAXAS2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD22 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATE1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C10orf82 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC172 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPXM2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP26A1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C18 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMBT1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMX2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENO4 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENTPD1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXOC6 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM204A 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM53B 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGFR2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HELLS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT5 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNK18 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LHPP 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPF 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPJ 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPM 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPN 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MKI67 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOC3L 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OAT 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDE6C 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDLIM1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLCE1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIP 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNLS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHTN1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAMBPL1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TACC2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TLL2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VAX1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR11 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZRANB1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACADSB 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLNK 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BTBD16 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BUB3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP55 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C8 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C9 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DHX32 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDRF1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM24B 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FRA10AC1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR26 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HMX3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IDE 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT1B 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLLN 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGI1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NKX1-2 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE4A 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKD2L1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBP4 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35G1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNKS2 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF518A 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RB1 52 / 83 cases (63 %) · ssm · rbl_mskcc_2020 | — | — | Retinoblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYD88 37 / 86 cases (43 %) · ssm · pcnsl_msk_2024 | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIM1 33 / 86 cases (38 %) · ssm · pcnsl_msk_2024 | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CD79B 20 / 86 cases (23 %) · ssm · pcnsl_msk_2024 | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALK 64 / 471 cases (14 %) · ssm · nbl_target_gdc · largest of 3 cohorts | — | — | Neuroblastoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATRX 24 / 223 cases (11 %) · ssm · nbl_msk_2023 | — | — | Neuroblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTCH1 51 / 491 cases (10 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 50 / 491 cases (10 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DDX3X 43 / 491 cases (8.8 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 34 / 491 cases (6.9 %) · ssm · mbl_dkfz_2017 · largest of 2 cohorts | — | — | Medulloblastoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTNNB1 32 / 491 cases (6.5 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 29 / 491 cases (5.9 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMARCA4 25 / 491 cases (5.1 %) · ssm · mbl_dkfz_2017 | — | — | Medulloblastoma | 1 | Observed | cbioportal | graph → |